# Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

> **NCT05268783** · NA · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 1000 (estimated)

## Conditions studied

- Quality of Life

## Interventions

- **PROCEDURE:** EORTC QLQ-C30
- **PROCEDURE:** EORTC QLQ-GI.NET21
- **PROCEDURE:** Satisfaction survey

## Key facts

- **NCT ID:** NCT05268783
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-11-05
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05268783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05268783, "Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05268783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*